Links and Resources

• 2018 TATFAR meeting opening session
• 2017 Pull Incentives for Antibacterial Drug Development: An Analysis by the TATFAR
• 2016 Economic Incentives for Antibacterial Drug Development: Literature Review and Considerations from the TATFAR
• 2016 Economic Incentives for Antimicrobial Therapy Development: Summary from the TATFAR [PDF – 28 pages] (Full Report) 2016 Report on Recommendation 18 [PDF – 33 pages]
• 2015  Report on the modified Delphi process for common structure and process indicators for hospital antimicrobial stewardship programs [PDF – 1.7 MB]
• 2014 TATFAR Progress report [ PDF – 86 pages ]
• 2011 TATFAR Report [ PDF – 47 pages ]
• 2011 EU-U.S. Workshop Report [ PDF – 13 pages ]
• 2009 EU-U.S. Summit Declaration [ PDF – 6 pages ]

Antibiotic Resistance Action Plans

• Norwegian National Strategy Against Antibiotic Resistance 2015-2020
• Tackling Antimicrobial Resistance and Antimicrobial Use: A Pan-Canadian Framework for Action
• A European One Health Action Plan against Antimicrobial Resistance (AMR)
• United States National Action Plan for Combating Antibiotic-Resistant Bacteria [PDF – 63 pages]
  • Progress Report for Years 1 and 2

 Centers for Disease Control and Prevention

• Initiatives for Addressing Antimicrobial Resistance in the Environment are two corresponding reports published in 2018 providing an overview of the current evidence base and ongoing knowledge gaps around antibiotic resistant in the environment (e.g., water, soil) and the potential effect on human health.
  • Executive Summary [PDF – 16 pages] (2018)
  • Current Situation and Challenges [PDF – 93 pages] (2018)
• Antibiotic Use in the United States, 2017: Progress and Opportunities
• Antibiotic Resistant Threats in the United States, CDC, 2013 [PDF – 114 pages]

European Commission

• Research, Innovation, and Policy: An Alliance Combating AMR, 2019
• A European One Health Action Plan against Antimicrobial Resistance, 2017 [PDF – 24 pages]
• Progress report on the Action plan against the rising threats from Antimicrobial
  Resistance, 2015 [PDF – 47 pages]
• Action plan against the rising threats from Antimicrobial Resistance, 2011 [PDF – 17 pages]

European Centre for Disease Prevention and Control

• ECDC/EFSA/EMA second joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals, 2017 [PDF – 135 pages]
• ECDC/EFSA/EMA first joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals, 2015 [PDF – 114 pages]
• Antimicrobial Resistance in Europe, ECDC, 2011 [PDF- 208 pages]
• The Bacterial Challenge: Time to React, ECDC, 2009 [PDF-54 pages]

European Food Safety Authority

• EFSA/ECDC European Union summary report on antimicrobial resistance in zoonotic indicator bacteria from humans, animals and food in 2013, 2015 [PDF – 178 pages]
• Fact Sheet on Antimicrobial Resistance [PDF- 2 pages]

European Medicines Agency

• Report on the event “Best use of medicines legislation to bring new antibiotics to patients and combat the resistance problem” [PDF-4 pages]

U.S. Food and Drug Administration

• Guidance for Industry #209, The Judicious Use of Medically Important Antibiotics in Food Producing Animals, FDA, 2012 [PDF-26 pages]

U.S. National Institute of Allergy and Infectious Diseases

• NIAID’s Antibacterial Resistance Program: Current Status and Future Directions, NIAID, 2014 [PDF-15 pages]

Find funding opportunities related to AMR on the agency or organization website, or reach out to a contact listed for more information.